Skip to main content
. 2020 Apr 7;11:226. doi: 10.3389/fneur.2020.00226

Figure 3.

Figure 3

Comparison of medication use patterns. The percentage of participants who treated their attacks only with REN and avoided medications in all their reported attacks in the open-label extension phase (black) compared with the run-in phase (gray). *p < 0.0001.